FDA Approves ADHD Breakthrough, Cancer Vaccine Uses Covid Immunity, Larger Paranthropus Boisei Revealed, Antibiotic Resistance Soars in Poultry, and more... episode artwork

EPISODE · Jul 28, 2026 · 10 MIN

FDA Approves ADHD Breakthrough, Cancer Vaccine Uses Covid Immunity, Larger Paranthropus Boisei Revealed, Antibiotic Resistance Soars in Poultry, and more...

from Science News Daily · host brief.news

(0:10): FDA Approves Simtriyo, First-of-Its-Kind ADHD Treatment for Adults and Children(2:06): Revolutionary Cancer Vaccine Uses COVID-19 Immunity to Target Tumors, Nears Human Trials(4:27): New Footprint Evidence Suggests Larger Size for Paranthropus boisei or Greater Variability in Homo erectus(6:19): Industrial Chicken Farming Fuels Antibiotic-Resistant Campylobacter Spread, Study Warns(8:25): MIT Develops Recyclable Yarn to Transform Textile Waste into Circular Fashion EconomyTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Clarivate

Episode metadata supplied by the publisher feed · Published Jul 28, 2026

Embed this episode

Ready to play

FDA Approves ADHD Breakthrough, Cancer Vaccine Uses Covid Immunity, Larger Paranthropus Boisei Revealed, Antibiotic Resistance Soars in Poultry, and more...

0:00 10:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science News Daily?

This episode is 10 minutes long.

When was this Science News Daily episode published?

This episode was published on July 28, 2026.

Can I download this Science News Daily episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!